| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9775 |
| Human Intestinal Absorption | HIA+ | 0.9962 |
| Caco-2 Permeability | Caco2- | 0.5349 |
| P-glycoprotein Substrate | Non-substrate | 0.8489 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9424 |
| Non-inhibitor | 0.9975 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9073 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8309 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7125 |
| CYP450 2D6 Substrate | Non-substrate | 0.8623 |
| CYP450 3A4 Substrate | Non-substrate | 0.6628 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6928 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8553 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9105 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8204 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8270 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9735 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8041 |
| Non-inhibitor | 0.9685 |
| AMES Toxicity | Non AMES toxic | 0.9132 |
| Carcinogens | Non-carcinogens | 0.8853 |
| Fish Toxicity | High FHMT | 0.8937 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9430 |
| Honey Bee Toxicity | Low HBT | 0.8648 |
| Biodegradation | Not ready biodegradable | 0.8451 |
| Acute Oral Toxicity | III | 0.8027 |
| Carcinogenicity (Three-class) | Non-required | 0.6202 |